Vukčević, M.; Šerović, K.; Despot, M.; Nikolić-Kokić, A.; Vujović, A.; Nikolić, M.; Blagojević, D.; Jovanović, T.; Despot, D.
Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity. Pharmaceuticals 2024, 17, 122.
https://doi.org/10.3390/ph17010122
AMA Style
Vukčević M, Šerović K, Despot M, Nikolić-Kokić A, Vujović A, Nikolić M, Blagojević D, Jovanović T, Despot D.
Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity. Pharmaceuticals. 2024; 17(1):122.
https://doi.org/10.3390/ph17010122
Chicago/Turabian Style
Vukčević, Marija, Katarina Šerović, Mateja Despot, Aleksandra Nikolić-Kokić, Aleksandra Vujović, Milan Nikolić, Duško Blagojević, Tanja Jovanović, and Dragana Despot.
2024. "Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity" Pharmaceuticals 17, no. 1: 122.
https://doi.org/10.3390/ph17010122
APA Style
Vukčević, M., Šerović, K., Despot, M., Nikolić-Kokić, A., Vujović, A., Nikolić, M., Blagojević, D., Jovanović, T., & Despot, D.
(2024). Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity. Pharmaceuticals, 17(1), 122.
https://doi.org/10.3390/ph17010122
